Literature DB >> 29738376

NaoXinTong Capsule Inhibits Carrageenan-Induced Thrombosis in Mice.

Qi Li1,2, Yi Chen1,2, Dan Zhao1,2, Zhuo Wei1,2, Shuang Zhang1,2, Yuanli Chen2, Yong Wang3, Ke Qian3, Buchang Zhao3, Yan Zhu4, Xiumei Gao4, Pengzhi Dong4, Xiaoju Li1,2, Yajun Duan2, Jihong Han1,2, Xiaoxiao Yang2.   

Abstract

Formation of thrombosis is mainly associated with dysfunctions of endothelial cells. NaoXinTong capsule (NXT), a traditional Chinese medicine, has been demonstrated multiple protective effects on vascular systems. However, it is unknown the effect of NXT on thrombosis. In this study, we determined whether NXT can inhibit carrageenan-induced thrombosis and the underlying mechanisms. Two days after carrageenan injection, severe thrombi were found in blood vessels of mouse tail and liver. By contrast, thrombi were substantially reduced by NXT treatment, and the reduction was associated with reduced serum tumor necrosis factor α and P-selectin levels. In vitro, NXT reduced lipopolysaccharide-activated adhesion of THP-1 monocytes to human umbilical vein endothelial cells (HUVECs) by inhibiting expression of adhesion molecules and interleukin 6, and reducing production of mitochondrial superoxide that is related to activation of antioxidant enzymes expression. NXT also reduced oxidized low-density lipoprotein-activated adhesion of platelets to HUVECs. In addition, NXT protected HUVECs against clopidogrel-induced cell death by inhibiting expression of tumor necrosis factor-like cytokine 1A and activating expression of vascular endothelial growth factor α. Taken together, our study indicates the potential application of NXT in antithrombosis by multiple antithrombotic functions.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29738376     DOI: 10.1097/FJC.0000000000000592

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  2 in total

Review 1.  Mechanism and Potential Target of Blood-Activating Chinese Botanical Drugs Combined With Anti-Platelet Drugs: Prevention and Treatment of Atherosclerotic Cardiovascular Diseases.

Authors:  Dan Li; Yujuan Li; Shengjie Yang; Zongliang Yu; Yanwei Xing; Min Wu
Journal:  Front Pharmacol       Date:  2022-06-03       Impact factor: 5.988

2.  Pharmacological Investigation of Asphodelus tenuifolius Cav. for its Potential Against Thrombosis in Experimental Models.

Authors:  Humaira Gul; Ayesha Jamshed; Qaiser Jabeen
Journal:  Dose Response       Date:  2022-09-15       Impact factor: 2.623

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.